Allan J E, Doherty P C
Scand J Immunol. 1986 Aug;24(2):153-62. doi: 10.1111/j.1365-3083.1986.tb02081.x.
The inflammatory exudate found in cerebrospinal fluid (CSF) of mice 6 days after intracerebral infection with lymphocytic choriomeningitis virus (LCMV) contains substantial populations of both cytotoxic T lymphocytes (CTL) and natural killer (NK) cells. Removal of NK cell activity by in vivo treatment with antibody to the asialo GM1 ganglioside and studies with NK-deficient bg/bg mice did not clearly determine whether NK cells contribute in any way to the development of clinical LCM. However, the LCM disease process induced in cyclophosphamide-suppressed, LCMV-infected recipients by the adoptive transfer of LCMV-immune spleen cells occurs in the absence of NK cell effector function in spleen, lymph nodes, or CSF of the recipients, though potent CTL populations are present in all of these sites. In this situation, NK cells are apparently not required for the induction of neurological symptoms that are indistinguishable from those of classical LCM.
在感染淋巴细胞性脉络丛脑膜炎病毒(LCMV)的小鼠脑内感染6天后,在其脑脊液(CSF)中发现的炎性渗出物含有大量的细胞毒性T淋巴细胞(CTL)和自然杀伤(NK)细胞。通过用抗唾液酸GM1神经节苷脂抗体进行体内治疗去除NK细胞活性,以及对NK缺陷的bg/bg小鼠进行研究,均未明确确定NK细胞是否以任何方式促成临床LCM的发展。然而,在环磷酰胺抑制、LCMV感染的受体中,通过过继转移LCMV免疫脾细胞诱导的LCM疾病过程,在受体的脾脏、淋巴结或脑脊液中不存在NK细胞效应功能的情况下发生,尽管在所有这些部位都存在有效的CTL群体。在这种情况下,诱导与经典LCM难以区分的神经症状显然不需要NK细胞。